Our mission is to amplify the rare condition voice. One of the ways we achieve that is through collaborations across the community, from patients and caregivers to industry leaders in treatment research and development. To learn more, click here.

    The Impact of Pharmacy Benefit Managers and Most Favored Nation Policy on Biosimilar Adoption and Healthcare Costs

    Editor's Note: This article is an opinion piece shared with Patient Worthy from our partner network. Opinion pieces may not reflect the views of Patient Worthy, its employees, or any…

    Continue Reading The Impact of Pharmacy Benefit Managers and Most Favored Nation Policy on Biosimilar Adoption and Healthcare Costs

    Oliver’s Story with SynGAP

    Patient Worthy is honored to share Oliver's story on behalf of SynGAP Research Fund.  SRF is a global group of families committed to accelerating the science to cure SYNGAP1 &…

    Continue Reading Oliver’s Story with SynGAP